Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins
- PMID: 17266583
- DOI: 10.2174/092986707779313381
Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins
Abstract
Atherosclerosis and its complications represent the major cause of death in developed countries. Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A [HMGCoA] reductase and consequently inhibitors of cholesterol biosynthesis. Statins have been described as the most potent class of drugs to reduce serum cholesterol levels. In clinical trials, statins are beneficial in primary and secondary prevention of coronary heart disease. Statins, were initially designed as cholesterol-lowering drugs. However, these drugs, besides their lipid-lowering properties, exert a number of protective effects on the cardiovascular system that emerged over the past years. The benefits observed with statin treatment appear to be greater than that might be expected from reduction in lipid levels alone, suggesting effects beyond cholesterol lowering. These cholesterol-independent effects have been called "pleiotropic". The cholesterol-independent or "pleiotropic" effects of statins involve improvement of endothelial function, stability of atherosclerotic plaques, decrease of oxidative stress and inflammation, and inhibition of thrombogenic response. These pleiotropic effects of statins have been proposed as key properties of these drugs to reduce cardiovascular morbidity and mortality. The present review will emphasize the molecular mechanisms underlying the effects of statins on endothelial function and oxidative stress. In particular, inhibition of small GTP-binding proteins, Rho, Ras and Rac, which are regulated by isoprenoids [farnesyl pyrophosphate and geranylgeranyl pyrophosphate], seems to play an important role in mediating the pleiotropic effects of statins.
Similar articles
-
Pleiotropic effects of statins.Annu Rev Pharmacol Toxicol. 2005;45:89-118. doi: 10.1146/annurev.pharmtox.45.120403.095748. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822172 Free PMC article. Review.
-
Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.Arch Mal Coeur Vaiss. 2005 Jun;98(6):661-6. Arch Mal Coeur Vaiss. 2005. PMID: 16007821 Review.
-
Clinical implications for statin pleiotropy.Curr Opin Lipidol. 2005 Dec;16(6):624-9. doi: 10.1097/01.mol.0000191913.16321.60. Curr Opin Lipidol. 2005. PMID: 16276239 Review.
-
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.Am J Cardiol. 2005 Sep 5;96(5A):24F-33F. doi: 10.1016/j.amjcard.2005.06.009. Am J Cardiol. 2005. PMID: 16126020 Free PMC article. Review.
-
Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.Curr Drug Targets Cardiovasc Haematol Disord. 2005 Apr;5(2):127-34. doi: 10.2174/1568006043586198. Curr Drug Targets Cardiovasc Haematol Disord. 2005. PMID: 15853754 Review.
Cited by
-
Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia.Patient Prefer Adherence. 2019 Dec 13;13:2111-2118. doi: 10.2147/PPA.S231873. eCollection 2019. Patient Prefer Adherence. 2019. PMID: 31853174 Free PMC article.
-
Familial hypercholesterolemia: present and future management.Curr Cardiol Rep. 2011 Dec;13(6):527-36. doi: 10.1007/s11886-011-0219-9. Curr Cardiol Rep. 2011. PMID: 21938413 Free PMC article. Review.
-
Biodegradable Polymers Influence the Effect of Atorvastatin on Human Coronary Artery Cells.Int J Mol Sci. 2016 Jan 22;17(2):148. doi: 10.3390/ijms17020148. Int J Mol Sci. 2016. PMID: 26805825 Free PMC article.
-
Atorvastatin Treatment Does Not Alter Pulse Wave Velocity in Healthy Adults.Int Sch Res Notices. 2014 Nov 13;2014:239575. doi: 10.1155/2014/239575. eCollection 2014. Int Sch Res Notices. 2014. PMID: 27351006 Free PMC article.
-
HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.J Korean Med Sci. 2010 Jan;25(1):16-23. doi: 10.3346/jkms.2010.25.1.16. Epub 2009 Dec 26. J Korean Med Sci. 2010. PMID: 20052342 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous